Recent Business Highlights
Delivering affordable generic
alternatives in Unbranded Markets
15 NEW PRODUCTS LAUNCHED IN
NORTH AMERICA IN FISCAL 2018
First-To-Market launches of Palonosetron for Injection and
OTC Levocetirizine Tablets
•
Affordable alternative for complex, limited-competition products
Multiple limited-competition launches this fiscal year (Incl. Sevelamer, Doxorubicin Hydrochloride
Liposome Injection, Bivalirudin for Injection, and Ezetimibe & Simvastatin Tablets)
Other Product Launches in the U.S.
.
Melphalan Hydrochloride 50mg Powder for Injection
Clofarabine Injection for Intravenous Use
.
Metaxalone Tablets
•
Cefixime for Oral Suspension
Pipeline Updates
.
Positive DC outcome on Suboxone litigation
11
Launch preparations on track for on near-term big-ticket launchesView entire presentation